000 | 01156 a2200313 4500 | ||
---|---|---|---|
005 | 20250515135707.0 | ||
264 | 0 | _c20080930 | |
008 | 200809s 0 0 eng d | ||
022 | _a1537-2677 | ||
024 | 7 |
_a10.1097/IOP.0b013e3181829f7b _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGarrity, James A | |
245 | 0 | 0 |
_aBiologic response modifiers for ophthalmologists. _h[electronic resource] |
260 |
_bOphthalmic plastic and reconstructive surgery _c |
||
300 |
_a345-7 p. _bdigital |
||
500 | _aPublication Type: Comment; Journal Article | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aDacryocystitis _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aInfliximab |
650 | 0 | 4 | _aOphthalmology |
650 | 0 | 4 |
_aOrbital Pseudotumor _xdrug therapy |
700 | 1 | _aMatteson, Eric L | |
773 | 0 |
_tOphthalmic plastic and reconstructive surgery _gvol. 24 _gno. 5 _gp. 345-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/IOP.0b013e3181829f7b _zAvailable from publisher's website |
999 |
_c18274321 _d18274321 |